U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Bacitracin

Last Revision: May 1, 2019.

Estimated reading time: 1 minute

CASRN: 1405-87-4

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

Because it is poorly absorbed after topical application and oral ingestion, bacitracin is considered a low risk to the nursing infant.[1] Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.[2] Therefore, an alternate cream product is preferred for application to the breast.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Mupirocin, Ozenoxacin

References

1.
Leachman SA, Reed BR. The use of dermatologic drugs in pregnancy and lactation. Dermatol Clin. 2006;24:167-97. [PubMed: 16677965]
2.
Noti A, Grob K, Biedermann M et al. Exposure of babies to C(15)-C(45) mineral paraffins from human milk and breast salves. Regul Toxicol Pharmacol. 2003;38:317-25. [PubMed: 14623482]

Substance Identification

Substance Name

Bacitracin

CAS Registry Number

1405-87-4

Drug Class

  • Breast Feeding
  • Anti-Infective Agents, Local
  • Antibacterial Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK501430PMID: 30000490

Views

Related information

Similar articles in PubMed

  • Review Polymyxin B.[Drugs and Lactation Database (...]
    Review Polymyxin B.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Nystatin.[Drugs and Lactation Database (...]
    Review Nystatin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Acitretin.[Drugs and Lactation Database (...]
    Review Acitretin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Neomycin.[Drugs and Lactation Database (...]
    Review Neomycin.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Prilocaine.[Drugs and Lactation Database (...]
    Review Prilocaine.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...